Covered recipient · General Payments record
DIVYA JALOTA
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$2,252.27
- Reported across 109 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $495.85 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $303.68 | 20 |
| Teva Pharmaceuticals USA, Inc. | $72.96 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $34.75 | 2 |
| Biogen, Inc. | $30.84 | 1 |
| TG THERAPEUTICS, INC. | $29.46 | 1 |
| Genentech USA, Inc. | $24.16 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920202023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.71 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984934 | CMS |
| ABBVIE INC. | $18.76 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984936 | CMS |
| ABBVIE INC. | $18.19 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984938 | CMS |
| ABBVIE INC. | $14.44 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984940 | CMS |
| ABBVIE INC. | $28.47 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984942 | CMS |
| ABBVIE INC. | $18.78 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984944 | CMS |
| ABBVIE INC. | $24.74 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984946 | CMS |
| ABBVIE INC. | $4.07 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984948 | CMS |
| ABBVIE INC. | $2.06 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984950 | CMS |
| ABBVIE INC. | $16.12 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984952 | CMS |
| ABBVIE INC. | $9.84 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984954 | CMS |
| ABBVIE INC. | $15.47 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984956 | CMS |
| ABBVIE INC. | $8.48 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984958 | CMS |
| ABBVIE INC. | $7.31 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984960 | CMS |
| ABBVIE INC. | $4.89 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984962 | CMS |
| ABBVIE INC. | $17.80 | 08/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984964 | CMS |
| ABBVIE INC. | $9.24 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984966 | CMS |
| ABBVIE INC. | $33.69 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984968 | CMS |
| ABBVIE INC. | $25.35 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984970 | CMS |
| ABBVIE INC. | $17.27 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103984972 | CMS |
| Biogen, Inc. | $30.84 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104860326 | CMS |
| Genentech USA, Inc. | $24.16 | 10/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133002480 | CMS |
| Novartis Pharmaceuticals Corporation | $18.80 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086986328 | CMS |
| Novartis Pharmaceuticals Corporation | $15.95 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086986332 | CMS |
| Teva Pharmaceuticals USA, Inc. | $32.47 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151751786 | CMS |
| Teva Pharmaceuticals USA, Inc. | $20.69 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151751860 | CMS |
| Teva Pharmaceuticals USA, Inc. | $19.80 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151751906 | CMS |
| TG Therapeutics, Inc. | $29.46 | 04/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136890428 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.